Cargando…

Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study

BACKGROUND: Chronic cough (cough lasting for ≥8 weeks) can lead to significant impairment in quality of life (QoL). Using patient-reported outcomes, this cohort study assessed the perceived impact of chronic cough on QoL and everyday life in patients from outpatient hospital clinics with refractory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puente-Maestu, Luis, Dávila, Ignacio, Quirce, Santiago, Crespo-Lessmann, Astrid, Martínez-Moragón, Eva, Sola, Javier, Nieto, María Luisa, González-Barcala, Francisco Javier, Cea-Calvo, Luis, Sánchez-Jareño, Marta, Rivas-Pardinas, Cristina, Domingo, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518856/ https://www.ncbi.nlm.nih.gov/pubmed/37753282 http://dx.doi.org/10.1183/23120541.00425-2023

Ejemplares similares

Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study
por: Dávila, Ignacio, et al.
Publicado: (2023)

A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients
por: Puente-Maestu, Luis, et al.
Publicado: (2021)

Basic assessment of chronic cough in primary care and referral pathways of patients to different specialists
por: Domingo, Christian, et al.
Publicado: (2023)

Use of Guidelines and Protocols for the Management of Chronic Cough. A Physician's Survey
por: Domínguez-Ortega, Javier, et al.
Publicado: (2022)

Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?
por: Sundar, Krishna M., et al.
Publicado: (2021)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Prevalence of chronic cough and patient characteristics in adults in Spain: A population-based cross-sectional survey
por: Domínguez-Ortega, Javier, et al.
Publicado: (2022)

Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
por: Nguyen, Allison Martin, et al.
Publicado: (2022)

Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework
por: Kum, Elena, et al.
Publicado: (2021)

Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
por: Ueda, Naoya, et al.
Publicado: (2022)

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023)

New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study
por: Zhang, Mengru, et al.
Publicado: (2023)

Management of chronic unexplained cough
por: Al-Hajjaj, Mohamed S.
Publicado: (2017)

Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis
por: Domingo, Christian, et al.
Publicado: (2022)

Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2017)

Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
por: Kum, Elena, et al.
Publicado: (2022)

Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis
por: Zheng, Ziwen, et al.
Publicado: (2023)

Effectiveness of proton pump inhibitor in unexplained chronic cough
por: Park, Hye Jung, et al.
Publicado: (2017)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020)

Epidemiology of unexplained chronic cough in adults: a population-based study
por: Arinze, Johnmary T., et al.
Publicado: (2023)

Este es el momento
por: Puente-Maestú, Luis
Publicado: (2021)

Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
por: Morice, Alyn H., et al.
Publicado: (2021)

Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease
por: Mohammed, Sana, et al.
Publicado: (2020)

Gabapentin for Chronic Refractory Cancer Cough
por: Atreya, Shrikant, et al.
Publicado: (2016)

Management of chronic refractory cough in adults
por: Visca, Dina, et al.
Publicado: (2020)

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
por: Martínez-Moragón, Eva, et al.
Publicado: (2021)

State of the Art for Refractory Cough: Multidisciplinary Approach
por: Vertigan, Anne E.
Publicado: (2023)

Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough
por: Ryan, Nicole M, et al.
Publicado: (2010)

Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough
por: Long, Li, et al.
Publicado: (2019)

Hyperinflation and its management in COPD
por: Puente-Maestu, Luis, et al.
Publicado: (2006)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2022)

ATP, an attractive target for the treatment of refractory chronic cough
por: Zhang, Mengru, et al.
Publicado: (2022)

Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy
por: Slovarp, Laurie J., et al.
Publicado: (2021)

Long-COVID severe refractory cough: discussion of a case with 6-week longitudinal cough characterization
por: Kang, Yu Ri, et al.
Publicado: (2022)

Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial
por: Slovarp, Laurie J., et al.
Publicado: (2023)

Papel de los receptores toll-like en las enfermedades respiratorias
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2010)

Role of toll-like receptors in respiratory diseases
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2010)

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
por: Badri, Huda, et al.
Publicado: (2022)

Sodium channel myotonia may be associated with high-risk brief resolved unexplained events
por: Cea, Gabriel, et al.
Publicado: (2020)

Different Associations of Intentional and Non-Intentional Non-Adherence Behaviors with Patient Experience with Healthcare and Patient Beliefs in Medications: A Survey of Patients with Chronic Conditions
por: Cea-Calvo, Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_236m2st7ji4132vv8fiubsgi53